DE2557425A1
(de)
|
1975-12-19 |
1977-06-30 |
Boehringer Sohn Ingelheim |
Chinazolonderivate
|
DE3704203A1
(de)
|
1987-02-11 |
1988-08-25 |
Boehringer Ingelheim Kg |
Verwendung von oxochinazolinderivaten bei der behandlung der hyperurikaemie
|
US5244911A
(en)
|
1991-03-28 |
1993-09-14 |
Eli Lilly And Company |
6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
|
US5153185A
(en)
|
1991-04-16 |
1992-10-06 |
Merck & Co., Inc. |
2-phenanthridonyl carbapenems
|
US5294610A
(en)
|
1992-10-15 |
1994-03-15 |
Merck & Co. Inc. |
2-(aza-9-fluorenonyl)carbapenem antibacterial agents
|
US5262564A
(en)
|
1992-10-30 |
1993-11-16 |
Octamer, Inc. |
Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
|
WO1994014777A1
(en)
|
1992-12-28 |
1994-07-07 |
Eisai Co., Ltd. |
Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar)
|
AU6122994A
(en)
|
1993-01-15 |
1994-08-15 |
Agouron Pharmaceuticals, Inc. |
Hiv protease inhibitors and their preparation
|
US5384317A
(en)
|
1993-08-02 |
1995-01-24 |
Merck & Co., Inc. |
Bridged biphenyl carbapenem compounds, compositions containing such compounds and methods of use
|
US6420127B1
(en)
|
1994-11-18 |
2002-07-16 |
Washington University |
Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
|
US6872542B1
(en)
|
1993-11-18 |
2005-03-29 |
Siga Pharmaceuticals, Inc. |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria
|
EP0730601B1
(en)
|
1993-11-18 |
2004-07-14 |
Washington University |
Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
|
US6110913A
(en)
|
1994-01-04 |
2000-08-29 |
Novo Nordisk A/S |
N-substituted azaheterocyclic carboxylic acids and esters thereof
|
US5532261A
(en)
|
1994-12-12 |
1996-07-02 |
Merck & Co., Inc. |
Carbapenem antibiotics, compositions containing such compounds and methods of use
|
US5719144A
(en)
|
1995-02-22 |
1998-02-17 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
BR9606547A
(pt)
|
1995-08-02 |
1997-10-14 |
Uriach & Cia Sa J |
Novos derivados de pirimidona com atividade fungicida
|
US5728844A
(en)
|
1995-08-29 |
1998-03-17 |
Celgene Corporation |
Immunotherapeutic agents
|
EP0845026A1
(de)
|
1996-06-19 |
1998-06-03 |
CALL, Hans-Peter Dr. |
Mehrkomponentensystem zur verwendung mit waschaktiven substanzen
|
DE19726241A1
(de)
|
1997-06-20 |
1998-12-24 |
Call Krimhild |
Erweitertes enzymatisches Multikomponentensystem zur Behandlung von Abwässern, zur Herstellung von Holzverbundstoffen, zum Deinken von Altpapier, Colour stripping von Altpapier, zum Einsatz als Oxidationssystem bei der organischen Synthese und zum Einsatz bei der Kohleverflüssigung
|
IL121748A0
(en)
|
1997-09-11 |
1998-02-22 |
Yeda Res & Dev |
Vanadium complexes of hydroxamates and pharmaceutical compositions comprising them
|
US6403632B1
(en)
|
2000-03-01 |
2002-06-11 |
Bristol Myers Squibb Pharma Co |
Lactam metalloprotease inhibitors
|
US6180640B1
(en)
|
1998-06-25 |
2001-01-30 |
Sepracor, Inc. |
Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto
|
JP2000044562A
(ja)
|
1998-07-31 |
2000-02-15 |
Kyowa Hakko Kogyo Co Ltd |
ピロロフタルイミド誘導体
|
BR9915900A
(pt)
|
1998-12-04 |
2001-08-21 |
American Home Prod |
Composto, composição farmacêutica, e, processo para tratar ou inibir distúrbios associados com contração da musculatura lisa.
|
US6288099B1
(en)
|
1998-12-04 |
2001-09-11 |
American Home Products Corporation |
Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
|
US6946473B2
(en)
|
1999-01-27 |
2005-09-20 |
Wyeth Holdings Corporation |
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
|
JP2000357809A
(ja)
|
1999-06-15 |
2000-12-26 |
Fuji Photo Film Co Ltd |
光電変換材料、光電変換素子及びポリメチン色素
|
JP4162106B2
(ja)
|
1999-06-17 |
2008-10-08 |
富士フイルム株式会社 |
光電変換素子および光電気化学電池ならびに金属錯体色素
|
AU6525300A
(en)
|
1999-08-13 |
2001-03-13 |
Sepracor, Inc. |
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
|
JP2001226269A
(ja)
|
2000-02-18 |
2001-08-21 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
CA2426942C
(en)
|
2000-10-31 |
2014-06-03 |
Mark P. Wentland |
8-carboxamido-2,6-methano-3-benzazocines
|
WO2002036066A2
(en)
|
2000-11-01 |
2002-05-10 |
Yeda Research And Development Co. Ltd. |
Pharmaceutical compositions comprising organic vanadium complexes for treatment of ischemia
|
US6642252B2
(en)
|
2000-11-07 |
2003-11-04 |
Bristol-Myers Squibb Company |
Acid derivatives useful as serine protease inhibitors
|
US7214690B2
(en)
|
2001-02-23 |
2007-05-08 |
Ligand Pharmaceuticals Incorporated |
Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
|
IN192526B
(es)
|
2001-09-25 |
2004-04-24 |
Ranbaxy Lab |
|
FR2832711B1
(fr)
|
2001-11-26 |
2004-01-30 |
Warner Lambert Co |
Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
WO2003087059A2
(en)
|
2002-04-08 |
2003-10-23 |
Sun Pharmaceutical Industries Limited |
(e)-oxime ether derivative of 5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one
|
TW200404796A
(en)
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
AU2003255845A1
(en)
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
WO2004041285A1
(en)
|
2002-10-31 |
2004-05-21 |
Amgen Inc. |
Antiinflammation agents
|
WO2004056182A1
(en)
|
2002-12-20 |
2004-07-08 |
Basf Aktiengesellschaft |
Pesticidal dibenzo(hetero)azepine derivatives
|
JP2004210716A
(ja)
|
2002-12-27 |
2004-07-29 |
Dai Ichi Seiyaku Co Ltd |
ジアミド誘導体
|
WO2004063156A1
(en)
|
2003-01-08 |
2004-07-29 |
Biovitrum Ab |
Novel indole derivates as fabp-4 inhibitors
|
US7704756B2
(en)
|
2003-01-21 |
2010-04-27 |
Novartis Vaccines And Diagnostics, Inc. |
Fluorogenic dyes
|
US7241775B2
(en)
|
2003-03-24 |
2007-07-10 |
Sanofi-Aventis Deutschland Gmbh |
Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
|
US7723349B2
(en)
|
2003-04-24 |
2010-05-25 |
Incyte Corporation |
Aza spiro alkane derivatives as inhibitors of metalloproteases
|
GB0313766D0
(en)
|
2003-06-13 |
2003-07-23 |
Xenova Ltd |
Pharmaceutical compounds
|
WO2005028478A1
(en)
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
WO2005108367A1
(en)
|
2004-05-03 |
2005-11-17 |
Envivo Pharmaceuticals, Inc. |
Compounds for treatment of neurodegenerative diseases
|
MXPA06013315A
(es)
|
2004-05-17 |
2007-02-02 |
Tibotec Pharm Ltd |
1,5-dihidro-pirido[3,2-b]indol-2-onas 4-sustituidas.
|
JP2008501766A
(ja)
|
2004-06-09 |
2008-01-24 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
置換された三環式のベンゾイミダゾール
|
WO2005123089A2
(en)
|
2004-06-10 |
2005-12-29 |
Kalypsys, Inc. |
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
|
AR051041A1
(es)
|
2004-10-04 |
2006-12-13 |
Altana Pharma Ag |
Bencimidazoles triciclicos condensados
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
WO2006065842A2
(en)
|
2004-12-13 |
2006-06-22 |
Synta Pharmaceuticals Corp. |
5,6,7,8-tetrahydroquinolines and related compounds and uses thereof
|
US8318699B2
(en)
|
2005-01-31 |
2012-11-27 |
The Trustees Of The University Of Pennsylvania |
Tumor necrosis factor inhibitors
|
AU2006226861B2
(en)
|
2005-03-22 |
2012-08-16 |
Dana-Farber Cancer Institute, Inc. |
Treatment of protein degradation disorders
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
AR057061A1
(es)
|
2005-06-16 |
2007-11-14 |
Altana Pharma Ag |
Espiro-bencimidazoles farmaceuticamente activos y su uso en la fabricacion de medicamentos
|
JP2008543867A
(ja)
|
2005-06-17 |
2008-12-04 |
ワイス |
セロトニン阻害剤ならびに5−ht1aアゴニストおよびアンタゴニストとして有用な三環系化合物
|
US20080280855A1
(en)
|
2005-06-22 |
2008-11-13 |
Nycomed Gmbh |
Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles
|
WO2007023135A1
(en)
|
2005-08-22 |
2007-03-01 |
Nycomed Gmbh |
Isotopically substituted benzimidazole derivatives
|
KR20080052611A
(ko)
|
2005-08-26 |
2008-06-11 |
메틸진 인크. |
히스톤 탈아세틸 효소의 벤조디아제핀 및 벤조피페라진유도체 억제제
|
GB0518237D0
(en)
|
2005-09-07 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
GB0522881D0
(en)
|
2005-11-10 |
2005-12-21 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
CA2630562C
(en)
|
2005-11-22 |
2013-12-31 |
Merck & Co., Inc. |
Tricyclic compounds useful as inhibitors of kinases
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
JP2009519998A
(ja)
|
2005-12-19 |
2009-05-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
アミノアルコール誘導体の過活動膀胱の治療の為の使用
|
DE102005061655A1
(de)
|
2005-12-22 |
2007-06-28 |
Merck Patent Gmbh |
Diazepinone
|
PE20071240A1
(es)
|
2006-01-17 |
2008-01-14 |
Schering Corp |
Compuestos derivados de hidantoina para el tratamiento de trastornos inflamatorios
|
CA2642273C
(en)
|
2006-02-14 |
2016-09-20 |
President And Fellows Of Harvard College |
Bifunctional histone deacetylase inhibitors
|
WO2007100536A1
(en)
|
2006-02-24 |
2007-09-07 |
Wyeth |
DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
|
WO2007109178A2
(en)
|
2006-03-16 |
2007-09-27 |
Pharmacyclics, Inc. |
Indole derivatives as inhibitors of histone deacetylase
|
US20080004306A1
(en)
|
2006-04-10 |
2008-01-03 |
Painceptor Pharma Corporation |
Compositions and methods for modulating gated ion channels
|
WO2008036445A2
(en)
|
2006-06-12 |
2008-03-27 |
Viamet Pharmaceuticals, Inc. |
Metallo-hydrolase inhibitors using metal binding moieties in combination with targeting moieties
|
TW200808707A
(en)
|
2006-06-14 |
2008-02-16 |
Methylgene Inc |
Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
|
CN101108859A
(zh)
|
2006-07-17 |
2008-01-23 |
上海恒瑞医药有限公司 |
长春碱类化合物、其制备方法及其在医药上的用途
|
JP2009544732A
(ja)
|
2006-07-26 |
2009-12-17 |
ノバルティス アクチエンゲゼルシャフト |
ウンデカプレニルピロホスフェートシンターゼの阻害剤
|
WO2008030120A1
(en)
|
2006-09-07 |
2008-03-13 |
Auckland Uniservices Limited |
A method for the fluorescent detection of nitroreductase activity using nitro-substituted aromatic compounds
|
WO2008048648A2
(en)
|
2006-10-17 |
2008-04-24 |
Acadia Pharmaceuticals Inc. |
Cb1-modulating compounds and their use
|
WO2008046155A1
(en)
|
2006-10-20 |
2008-04-24 |
Dia-B Tech Limited |
Methods for regulating glucose homeostasis and agents therefor
|
CL2007003108A1
(es)
|
2006-10-28 |
2008-07-18 |
Methylgene Inc Envivo Pharmace |
Compuestos derivados de n-hidroxiamida sustituida con heterociclos, inhibidores de histona desacetilasa; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad del grupo que consiste en enfermedad de huntington,
|
US8962825B2
(en)
|
2006-10-30 |
2015-02-24 |
Glaxosmithkline Intellectual Property Development Limited |
Hydroxamates as inhibitors of histone deacetylase
|
US7820711B2
(en)
|
2006-11-14 |
2010-10-26 |
Pharmacyclics Inc. |
Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders
|
US20110150825A1
(en)
|
2006-11-14 |
2011-06-23 |
Pharmacyclics, Inc. |
Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions
|
CA2673108A1
(en)
|
2006-12-08 |
2008-06-19 |
Merck & Co., Inc. |
Constrained spirocyclic compounds as cgrp receptor antagonists
|
WO2008071765A1
(en)
|
2006-12-14 |
2008-06-19 |
Nycomed Gmbh |
Pharmaceutically active spiro-substituted benzimidazole derivatives
|
WO2008074858A1
(en)
|
2006-12-21 |
2008-06-26 |
Nycomed Gmbh |
Intermediates and process for the production of 5-substituted tricyclic benzimidazoles
|
MX2009008463A
(es)
|
2007-02-09 |
2010-01-27 |
Forest Lab Holdings Ltd |
Formulaciones biodisponibles de compuestos heterociclicos.
|
WO2008101186A1
(en)
|
2007-02-15 |
2008-08-21 |
The J. David Gladstone Institutes |
Inhibitors for hdac8
|
DE102007013856A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Substituierte Tetrahydropyrrolochinoline
|
DE102007013854A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Tetrahydrochinoline
|
DE102007013855A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Substituierte Tetrahydrochinoline
|
US20090105283A1
(en)
|
2007-04-11 |
2009-04-23 |
Dmitry Koltun |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
US20080255161A1
(en)
|
2007-04-11 |
2008-10-16 |
Dmitry Koltun |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
AR067329A1
(es)
|
2007-06-13 |
2009-10-07 |
Bristol Myers Squibb Co |
Analogos dipeptidos como inhibidores del factor de coagulacion
|
US8148380B2
(en)
|
2007-07-23 |
2012-04-03 |
Crestone, Inc. |
Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
|
PE20091315A1
(es)
|
2008-01-09 |
2009-09-21 |
Array Biopharma Inc |
Ciclopentanos de pirimidilo como inhibidores de la proteina cinasa akt
|
US8987468B2
(en)
|
2008-02-04 |
2015-03-24 |
The Translational Genomics Research Institute |
Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
|
US20110098267A1
(en)
|
2008-02-07 |
2011-04-28 |
Synta Pharmaceuticals Corporation |
Topical formulations for the treatment of psoriasis
|
JP2009191041A
(ja)
|
2008-02-18 |
2009-08-27 |
Univ Of Tokyo |
ヒドロキシメチルケトン誘導体
|
EP2100879A1
(en)
|
2008-03-13 |
2009-09-16 |
4Sc Ag |
Novel N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
EP2311840A1
(en)
|
2009-10-13 |
2011-04-20 |
DAC S.r.l. |
Spirocyclic derivatives as histone deacetylase inhibitors
|
EP2110377A1
(en)
|
2008-04-15 |
2009-10-21 |
DAC S.r.l. |
Spirocyclic derivatives as histone deacetylase inhibitors
|
US8980877B2
(en)
|
2008-04-15 |
2015-03-17 |
Dac S.R.L. |
Spirocyclic derivatives as histone deacetylase inhibitors
|
WO2009137503A1
(en)
|
2008-05-05 |
2009-11-12 |
Envivo Pharmaceuticals, Inc. |
Hdac inhibitors and uses thereof
|
US8546410B2
(en)
|
2008-05-05 |
2013-10-01 |
Abbvie Inc. |
Heteroaryl-fused macrocyclic pyrimidine derivatives
|
WO2009152210A2
(en)
|
2008-06-12 |
2009-12-17 |
National Health Research Institutes |
Coumarin compounds and their use for treating cancer
|
WO2009151561A2
(en)
|
2008-06-12 |
2009-12-17 |
President And Fellows Of Harvard College |
Methods and compounds for antimicrobial intervention
|
EP2330894B8
(en)
|
2008-09-03 |
2017-04-19 |
BioMarin Pharmaceutical Inc. |
Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
|
CA2736130C
(en)
|
2008-09-11 |
2014-01-14 |
Amgen Inc. |
Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
|
WO2010042475A1
(en)
|
2008-10-07 |
2010-04-15 |
Schering Corporation |
Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
|
US8658641B2
(en)
|
2008-10-14 |
2014-02-25 |
Astrazeneca Ab |
Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
|
US9040528B2
(en)
|
2008-10-14 |
2015-05-26 |
Astrazeneca Ab |
Chemical compounds 542
|
WO2010056230A1
(en)
|
2008-10-15 |
2010-05-20 |
Cv Therapeutics, Inc. |
3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
US8569336B2
(en)
|
2008-11-10 |
2013-10-29 |
Ling Tong |
Compounds for the treatment of inflammatory disorders
|
WO2010056038A2
(ko)
|
2008-11-11 |
2010-05-20 |
제일약품주식회사 |
신규한 트리시클릭 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
|
US20110319416A1
(en)
|
2009-01-28 |
2011-12-29 |
Emory University |
Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
EA020898B1
(ru)
|
2009-03-27 |
2015-02-27 |
Мерк Шарп Энд Домэ Корп. |
Ингибиторы репликации вируса гепатита c
|
KR20120034592A
(ko)
|
2009-04-09 |
2012-04-12 |
베링거 인겔하임 인터내셔날 게엠베하 |
Hiv 복제의 저해제
|
WO2010125469A1
(en)
|
2009-04-29 |
2010-11-04 |
Glenmark Pharmaceuticals, S.A. |
Pyrimidinedione-fused heterocyclic compounds as trpa1 modulators
|
US9096518B2
(en)
|
2009-06-22 |
2015-08-04 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
WO2010151317A1
(en)
|
2009-06-22 |
2010-12-29 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
JP5868851B2
(ja)
|
2009-06-23 |
2016-02-24 |
ザ・トランスレーショナル・ジェノミクス・リサーチ・インスティチュート |
ベンズアミド誘導体
|
EP2266985A1
(en)
|
2009-06-26 |
2010-12-29 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Tricyclic Pyrimidine Derivatives as Wnt antagonists
|
WO2011002520A2
(en)
|
2009-07-02 |
2011-01-06 |
Angion Biomedica Corp. |
Small molecule inhibitors of parp activity
|
US8431538B2
(en)
|
2009-07-22 |
2013-04-30 |
The Board Of Trustees Of The University Of Illinois |
HDAC inhibitors and therapeutic methods of using same
|
JP2013505252A
(ja)
|
2009-09-16 |
2013-02-14 |
サイリーン ファーマシューティカルズ インコーポレーティッド |
三環式タンパク質キナーゼ調節剤
|
KR101428346B1
(ko)
|
2009-09-28 |
2014-08-07 |
에프. 호프만-라 로슈 아게 |
벤즈옥사제핀 pi3k 억제 화합물 및 사용 방법
|
JP5546636B2
(ja)
|
2009-09-28 |
2014-07-09 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ベンゾキセピンpi3k阻害剤化合物及び使用方法
|
EP2305643A1
(en)
|
2009-10-02 |
2011-04-06 |
Ikerchem, S.L. |
New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers
|
US9221773B2
(en)
|
2009-12-22 |
2015-12-29 |
The Translational Genomics Research Institute |
Benzamide derivatives
|
US8198290B2
(en)
|
2009-12-23 |
2012-06-12 |
Berry And Associates, Inc. |
Methoxatin derivatives
|
WO2011084991A2
(en)
|
2010-01-08 |
2011-07-14 |
President And Fellows Of Harvard College |
Fluorinated hdac inhibitors and uses thereof
|
AU2011205283B2
(en)
|
2010-01-13 |
2014-07-10 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
JP2011148714A
(ja)
|
2010-01-19 |
2011-08-04 |
Nippon Soda Co Ltd |
病害防除方法
|
EP2526093B1
(en)
|
2010-01-22 |
2016-08-17 |
Acetylon Pharmaceuticals, Inc. |
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
|
US8519122B2
(en)
|
2010-02-12 |
2013-08-27 |
The Regents Of The University Of California |
Compositions and methods for modification of biomolecules
|
US20110212969A1
(en)
|
2010-02-26 |
2011-09-01 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
US8546588B2
(en)
|
2010-02-26 |
2013-10-01 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
US8946223B2
(en)
|
2010-04-12 |
2015-02-03 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
JO3131B1
(ar)
|
2010-04-27 |
2017-09-20 |
Glaxosmithkline Llc |
مركبات كيميائية
|
WO2011146591A1
(en)
|
2010-05-19 |
2011-11-24 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
EP2582668B1
(en)
|
2010-06-16 |
2016-01-13 |
Bristol-Myers Squibb Company |
Carboline carboxamide compounds useful as kinase inhibitors
|
WO2012012320A1
(en)
|
2010-07-19 |
2012-01-26 |
Millenium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
WO2012012322A1
(en)
|
2010-07-19 |
2012-01-26 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
WO2012016081A2
(en)
|
2010-07-30 |
2012-02-02 |
The Regents Of The University Of California |
Method and therapeutic for the treatment and regulation of memory formation
|
US8471026B2
(en)
|
2010-08-26 |
2013-06-25 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
RU2577861C2
(ru)
|
2010-09-09 |
2016-03-20 |
Ф. Хоффманн-Ля Рош Аг |
N-гидрокси-бензамиды для лечения рака
|
US20130227717A1
(en)
|
2010-10-08 |
2013-08-29 |
Life Sciences Research Partners Vzw |
Hdac inhibitors to treat charcot-marie-tooth disease
|
WO2012045194A1
(en)
|
2010-10-09 |
2012-04-12 |
Abbott Laboratories |
Benzodiazepinones as fak inhibitors for treatment of cancer
|
WO2012054332A1
(en)
|
2010-10-18 |
2012-04-26 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
JP2013543840A
(ja)
|
2010-10-22 |
2013-12-09 |
ユニヴェルシテ・ドゥ・ストラスブール |
Hsp90関連病態の治療のために有用なポコキシム複合物
|
PT2640709T
(pt)
|
2010-11-16 |
2016-07-13 |
Acetylon Pharmaceuticals Inc |
Compostos de pirimidina hidroxiamida como inibidores de proteína desacetilase e métodos de utilização dos mesmos
|
CN102558200A
(zh)
|
2010-12-21 |
2012-07-11 |
复旦大学 |
长春碱类衍生物、其制备方法及其在医药上的用途
|
US8778931B2
(en)
|
2010-12-22 |
2014-07-15 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
WO2012085003A1
(en)
|
2010-12-22 |
2012-06-28 |
Katholieke Universiteit Leuven, K.U. Leuven R&D |
2-hydroxyisoquinoline-1,3(2h,4h)-diones and related compounds useful as hiv replication inhibitors
|
US8980909B2
(en)
|
2011-01-12 |
2015-03-17 |
Crystal Biopharmaceutical Llc |
HDAC inhibiting derivatives of camptothecin
|
WO2012102985A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxosmithkline Llc |
Isoquinoline compounds and methods for treating hiv
|
CA2825599C
(en)
|
2011-02-01 |
2021-07-13 |
The Board Of Trustees Of The University Of Illinois |
4-methyl-n-hydroxybenzamide compounds as histone deacetylase (hdac) inhibitors
|
CN103608346B
(zh)
|
2011-02-02 |
2016-06-15 |
菲布罗根有限公司 |
作为缺氧诱导因子(hif)羟化酶抑制剂的萘啶衍生物
|
US9346827B2
(en)
|
2011-02-07 |
2016-05-24 |
Amgen Inc. |
5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
|
WO2012112525A1
(en)
|
2011-02-14 |
2012-08-23 |
Alkermes, Inc. |
PERIPHERIALLY ACTING μ OPIOID ANTAGONISTS
|
US8962859B2
(en)
|
2011-02-15 |
2015-02-24 |
Amgen Inc. |
Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
|
WO2012110860A1
(en)
|
2011-02-17 |
2012-08-23 |
Glenmark Pharmaceuticals S.A. |
TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
|
WO2012117421A1
(en)
|
2011-03-02 |
2012-09-07 |
Orchid Research Laboratories Ltd |
Histone deacetylase inhibitors
|
BR112013024122A2
(pt)
|
2011-03-21 |
2019-09-24 |
Hoffmann La Roche |
compostos de benzoxazepina seletivos para p110 delta pi3k e métodos de uso
|
CN102838625B
(zh)
|
2011-06-22 |
2015-04-15 |
中国科学院上海药物研究所 |
四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途
|
US20150197497A1
(en)
|
2011-06-24 |
2015-07-16 |
Dana-Farber Cancer Institute, Inc. |
Selective inhibitors of histone deacetylase isoform 6 and methods thereof
|
WO2013006408A1
(en)
|
2011-07-01 |
2013-01-10 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
US9056843B2
(en)
|
2011-07-08 |
2015-06-16 |
Novartis Ag |
Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
|
WO2013009827A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
US9512083B2
(en)
|
2011-07-20 |
2016-12-06 |
The General Hospital Corporation |
Histone deacetylase 6 selective inhibitors for the treatment of bone disease
|
CN106518845B
(zh)
|
2011-08-30 |
2019-09-13 |
Chdi基金会股份有限公司 |
犬尿氨酸-3-单加氧酶抑制剂、药物组合物及其使用方法
|
WO2013044092A1
(en)
|
2011-09-21 |
2013-03-28 |
Amgen Inc. |
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
WO2013049725A2
(en)
|
2011-09-30 |
2013-04-04 |
Tufts University |
Methods of using adenosine a1 receptor activation for treating depression
|
WO2013052110A1
(en)
|
2011-10-03 |
2013-04-11 |
The Trustees Of Columbia University In The City Of New York |
Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
|
EP2769422B9
(en)
|
2011-10-18 |
2017-03-22 |
École Polytechnique Fédérale de Lausanne (EPFL) |
Compounds for electrochemical and/or optoelectronic devices
|
WO2013059582A2
(en)
|
2011-10-20 |
2013-04-25 |
Nupotential, Inc. |
Small molecule inhibitors of histone deacteylases
|
CN107011323A
(zh)
|
2011-12-11 |
2017-08-04 |
威尔金制药有限公司 |
金属酶抑制剂化合物
|
AU2012351806C1
(en)
|
2011-12-15 |
2016-06-16 |
Alkermes Pharma Ireland Limited |
Compositions of buprenorphine and mu-opioid receptor antagonists
|
CA2866707A1
(en)
|
2012-03-07 |
2013-09-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Selective histone deactylase 6 inhibitors
|
GB2503789A
(en)
|
2012-05-15 |
2014-01-08 |
Syngenta Participations Ag |
Quinazoline derivatives as antifungal agents
|
CN104507902A
(zh)
|
2012-07-10 |
2015-04-08 |
佐治亚州立大学研究基金会公司 |
蒽醌类似物以及其制备和使用方法
|
US20140018361A1
(en)
|
2012-07-11 |
2014-01-16 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
US9085586B2
(en)
|
2012-07-11 |
2015-07-21 |
Nimbus Iris, Inc. |
IRAK inhibitors and uses thereof
|
WO2014018919A1
(en)
|
2012-07-27 |
2014-01-30 |
The Regents Of The University Of California |
Seriniquinones, melanoma-specific anticancer agents
|
EP2892885A1
(de)
|
2012-09-05 |
2015-07-15 |
Bayer CropScience AG |
Herbizid wirksame bicycloarylcarbonsäureamide
|
ES2625959T3
(es)
|
2012-09-28 |
2017-07-21 |
Bayer Pharma Aktiengesellschaft |
5-Aril-triazolo-azepinas inhibidoras de la proteína BET
|
US9403850B2
(en)
|
2013-01-10 |
2016-08-02 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
CA2902080A1
(en)
|
2013-02-25 |
2014-08-28 |
Merck Patent Gmbh |
2-amino-3,4-dihydroquinazoline derivatives and the use thereof as cathepsin d inhibitors
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
RU2634694C2
(ru)
|
2013-04-29 |
2017-11-03 |
Чонг Кун Данг Фармасьютикал Корп. |
Новые соединения для селективных ингибиторов гистондеацетилазы и фармацевтическая композиция, включающая такие соединения
|
WO2014177469A1
(en)
|
2013-04-30 |
2014-11-06 |
Boehringer Ingelheim International Gmbh,M |
Diaminopyrazine compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
|
WO2015054474A1
(en)
|
2013-10-10 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
|
KR101697518B1
(ko)
|
2014-03-12 |
2017-01-19 |
주식회사 종근당 |
히스톤 탈아세틸화효소 6 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물
|
US10112915B2
(en)
|
2015-02-02 |
2018-10-30 |
Forma Therapeutics, Inc. |
3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
|
TW201636329A
(zh)
|
2015-02-02 |
2016-10-16 |
佛瑪治療公司 |
作為hdac抑制劑之雙環[4,6,0]異羥肟酸
|
TW201643139A
(zh)
|
2015-04-17 |
2016-12-16 |
佛瑪治療公司 |
作為組蛋白脫乙醯基酶抑制劑之3-螺環-6-異羥肟酸萘滿
|
US10494355B2
(en)
|
2015-10-12 |
2019-12-03 |
Chong Kun Dang Pharmaceutical Corp. |
Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
|
US10555935B2
(en)
|
2016-06-17 |
2020-02-11 |
Forma Therapeutics, Inc. |
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
|